CAMP4 Therapeutics Corporation (CAMP) Research

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Market snapshot

Symbol
CAMP
Price
$4.13
Day change
-0.24%
Market cap
$87.7M
P/E ratio
-2.77x
52-week range
1.305-7.75
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 2 months
Analyst price target
$6.50

Peer companies

  • Acrivon Therapeutics, Inc. Common Stock (ACRV)
  • ALX Oncology Holdings Inc. (ALXO)
  • aTyr Pharma, Inc. (ATYR)
  • Biomea Fusion, Inc. (BMEA)
  • MindWalk Holdings Corp. (HYFT)
  • PMV Pharmaceuticals, Inc. (PMVP)
  • Quince Therapeutics, Inc. (QNCX)
  • Repare Therapeutics Inc. (RPTX)

Recent insider activity

  • WILLIAMS DOUGLAS E — A-Award (28000 shares) on 2026-06-10
  • Young Richard A — A-Award (28000 shares) on 2026-06-10
  • Schwab Andrew J. — A-Award (28000 shares) on 2026-06-10
  • Holtzman Steven H — A-Award (28000 shares) on 2026-06-10
  • Stewart Murray — A-Award (28000 shares) on 2026-06-10

Open CAMP4 Therapeutics Corporation (CAMP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.